US4824432A
(en)
*
|
1981-03-24 |
1989-04-25 |
S.V.S. Laboratories, Inc. |
Method for treating AIDS and other immune deficiencies and immune disorders
|
US5130128A
(en)
*
|
1982-06-03 |
1992-07-14 |
Stolle Research & Development Corporation |
Use of honey as vaccine
|
US5932250A
(en)
*
|
1982-06-03 |
1999-08-03 |
Dcv, Inc. |
Anti-cholesterolemic egg, vaccine and method for production, and use
|
ES2052496T3
(es)
*
|
1985-11-25 |
1994-07-16 |
Ghen Corp |
Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
|
CA1336818C
(en)
*
|
1987-04-16 |
1995-08-29 |
International Institute Of Cellular And Molecular Pathology |
Treatment of allergy and composition thereof
|
US5565550A
(en)
*
|
1987-05-04 |
1996-10-15 |
Dana Farber Cancer Institute |
Antibodies to ICAM-2, and fragments thereof
|
US5284931A
(en)
*
|
1987-05-04 |
1994-02-08 |
Dana Farber Cancer Institute |
Intercellular adhesion molecules, and their binding ligands
|
JP2641228B2
(ja)
*
|
1988-01-22 |
1997-08-13 |
鐘紡株式会社 |
抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
|
US5059419A
(en)
*
|
1988-06-09 |
1991-10-22 |
Grand Laboratories, Inc. |
Streptococcus suis antiserum and its use in treating Streptococcus suis infections
|
JP2689511B2
(ja)
*
|
1988-08-18 |
1997-12-10 |
ライオン株式会社 |
食 品
|
US6511664B1
(en)
|
1989-03-09 |
2003-01-28 |
Dana Farber Cancer Institute |
Intercellular adhesion molecule—2 and its binding ligands
|
DE3924746A1
(de)
*
|
1989-07-26 |
1991-01-31 |
Behringwerke Ag |
Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
|
US6932968B1
(en)
|
1989-07-26 |
2005-08-23 |
Dade Behring Marburg Gmbh |
Erythropoietin (EPO) peptides and antibodies directed against these
|
US7005560B1
(en)
*
|
1989-10-27 |
2006-02-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
US5196193A
(en)
*
|
1989-10-31 |
1993-03-23 |
Ophidian Pharmaceuticals, Inc. |
Antivenoms and methods for making antivenoms
|
US5601823A
(en)
*
|
1989-10-31 |
1997-02-11 |
Ophidian Pharmaceuticals, Inc. |
Avian antitoxins to clostridium difficle toxin A
|
US5958413A
(en)
*
|
1990-11-01 |
1999-09-28 |
Celltech Limited |
Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
|
US5753228A
(en)
*
|
1992-08-25 |
1998-05-19 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
|
JP2553445B2
(ja)
*
|
1992-12-17 |
1996-11-13 |
同仁医薬化工株式会社 |
抗体の安定化方法
|
AU690521B2
(en)
*
|
1993-05-26 |
1998-04-30 |
Dcv, Inc. |
Anti-cholesterolemic egg, vaccine and method for production,and use
|
US6068862A
(en)
*
|
1993-06-30 |
2000-05-30 |
Taiyo Kagaku Co., Ltd. |
Tea-derived feed additive and animal feed containing the same
|
EP0739488A1
(en)
*
|
1994-01-14 |
1996-10-30 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
US5830479A
(en)
*
|
1994-02-09 |
1998-11-03 |
Willmar Poultry Company, Inc. |
Active immunization using a siderophore receptor protein
|
DE69535374T2
(de)
*
|
1994-02-09 |
2007-08-23 |
Epitopix Llc, Willmar |
Aktive immunisierung gegen ein siderophores rezeptorprotein
|
US5538733A
(en)
*
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
WO1996004933A2
(en)
*
|
1994-08-05 |
1996-02-22 |
Wisconsin Alumni Research Foundation |
Cck antibodies used to improve feed efficiency
|
US5814316A
(en)
*
|
1994-08-05 |
1998-09-29 |
Wisconsin Alumni Research Foundation |
Compound to mimick a naturally occurring peptide's effect
|
US5939269A
(en)
*
|
1994-12-28 |
1999-08-17 |
The Regents Of The University Of California |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
JPH11506424A
(ja)
*
|
1995-03-24 |
1999-06-08 |
オフィディアン ファーマシューティカルズ インコーポレーテッド |
ベロ毒素産生大腸菌に対する治療
|
FI955389A0
(fi)
*
|
1995-11-09 |
1995-11-09 |
Antti Sakari Aaltonen |
Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
|
EP0826005B1
(de)
*
|
1996-03-12 |
2004-05-12 |
Ovogenix Immunpharma GmbH |
Verwendung von aviären, vitellinen, gegen hiv-antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
|
US5807551A
(en)
*
|
1996-04-01 |
1998-09-15 |
Iowa State University Research Foundation, Inc. |
Method to provide artificial passive immunity in birds
|
US5725873A
(en)
*
|
1996-07-22 |
1998-03-10 |
Wisconsin Alumni Research Foundation |
Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
|
US5772999A
(en)
*
|
1996-07-30 |
1998-06-30 |
Dcv Biologics, L.P. |
Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
|
NZ335170A
(en)
*
|
1996-10-02 |
2001-08-31 |
Ovimmune Inc |
Oral administration of chicken yolk Ig-gamma antibodies to treat disease
|
JP3430853B2
(ja)
*
|
1997-04-11 |
2003-07-28 |
株式会社ゲン・コーポレーション |
胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
|
JPH10298105A
(ja)
*
|
1997-04-23 |
1998-11-10 |
Gen Corp:Kk |
腸管出血性大腸菌による感染症の予防剤および治療剤
|
WO1998055143A1
(en)
*
|
1997-06-04 |
1998-12-10 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
|
US6086878A
(en)
*
|
1997-08-21 |
2000-07-11 |
Dcv, Inc. |
Method of increasing muscle protein and reducing fat in animals
|
CZ287956B6
(cs)
*
|
1997-11-04 |
2001-03-14 |
Medipharm Cz, S. R. O. |
Perorální přípravek k prevenci a léčbě parvovirózy psů
|
US6395273B1
(en)
*
|
1998-06-10 |
2002-05-28 |
Promega Corporation |
Prevention and treatment of inflammatory bowel disease
|
JP2000351735A
(ja)
|
1999-04-09 |
2000-12-19 |
Akzo Nobel Nv |
カンピロバクターワクチン
|
US7238351B2
(en)
*
|
1999-07-15 |
2007-07-03 |
Peter Nash |
Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
|
US7241443B1
(en)
|
1999-07-15 |
2007-07-10 |
Camas Incorporated |
Immunogen adherence inhibitor and method of making and using same
|
AU6726500A
(en)
*
|
1999-08-24 |
2001-03-19 |
Nomoto, Kikuo |
Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
|
US6706267B1
(en)
*
|
1999-09-14 |
2004-03-16 |
Arkion Life Sciences Llc |
Glucosamine and egg for reducing inflammation
|
US6569447B2
(en)
|
2000-03-24 |
2003-05-27 |
Trouw Nutrition Usa, Llc |
Combination of plasma and hyperimmunized products for increased performance
|
US20030036639A1
(en)
*
|
2001-01-03 |
2003-02-20 |
Emery Daryll A. |
Immunizing compositions and methods of use
|
CA2339436A1
(fr)
|
2001-03-15 |
2002-09-15 |
Josee Harel |
Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
|
US20030017154A1
(en)
*
|
2001-05-18 |
2003-01-23 |
Hunchar Jeffrey G. |
Method of increasing uniformity in avians
|
CA2392344A1
(en)
*
|
2001-07-02 |
2003-01-02 |
Nutratech Inc. |
Method for removal of pathogens from a localized environment
|
US6770280B1
(en)
|
2001-11-15 |
2004-08-03 |
Humanetics Corporation |
Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
|
AU2002246753B8
(en)
*
|
2001-12-28 |
2009-09-24 |
Camas, Incorporated |
Organism adherence inhibitor and method of making and using same
|
KR100489615B1
(ko)
*
|
2002-01-30 |
2005-05-17 |
주식회사 단바이오텍 |
리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
|
AU2003216227A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Arkion Life Sciences Llc |
Purified cytokine inhibitory factor
|
US20040005327A1
(en)
*
|
2002-05-16 |
2004-01-08 |
Subramanian Iyer |
Immune T-cell stimulation
|
US6729265B2
(en)
*
|
2002-06-27 |
2004-05-04 |
Arkion Life Sciences Llc |
Supplemented antibody feed to enter the circulating system of newborns
|
CN1819844B
(zh)
*
|
2003-02-19 |
2012-02-22 |
彼得·纳什 |
免疫原粘附抑制剂及其制备和使用方法
|
US9701737B2
(en)
*
|
2003-02-19 |
2017-07-11 |
Camas, Incorporated |
Immunogen adherence and method of making and using same
|
AU2003236739A1
(en)
*
|
2003-07-07 |
2005-01-21 |
Luiz Fernando Mesquita |
Process of obtaining a freeze-dried complex from mammal gland secretion
|
ATE520709T1
(de)
*
|
2003-09-19 |
2011-09-15 |
Epitopix Llc |
Campylobacter-polypeptide und verwendungsverfahren
|
DE602005026287D1
(de)
*
|
2004-04-16 |
2011-03-24 |
Univ Alberta |
Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
|
US8877187B2
(en)
*
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
WO2007027321A2
(en)
*
|
2005-07-25 |
2007-03-08 |
Avianax, Inc. |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
US20070264264A1
(en)
*
|
2005-08-30 |
2007-11-15 |
La Belle Associates, Inc. |
Method and composition for conferring immunity in mammals
|
CA2521156A1
(en)
*
|
2005-09-16 |
2007-03-16 |
John Hare |
Antibodies as growth promoting agents
|
EP1790358A1
(en)
*
|
2005-11-23 |
2007-05-30 |
Université de Reims Champagne-Ardennes |
Protein constructs designed for targeting and lysis of cells
|
US20090317421A1
(en)
|
2006-01-18 |
2009-12-24 |
Dominique Missiakas |
Compositions and methods related to staphylococcal bacterium proteins
|
JP4753808B2
(ja)
*
|
2006-06-20 |
2011-08-24 |
アサマ化成株式会社 |
感染症予防食品添加用組成物
|
MX2009002893A
(es)
|
2006-09-18 |
2009-07-10 |
Raptor Pharmaceutical Inc |
Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
|
US8282928B2
(en)
*
|
2007-05-30 |
2012-10-09 |
The Governors Of The University Of Alberta |
Anti-gluten egg yolk antibodies for the treatment of celiac disease
|
RU2491937C2
(ru)
|
2007-07-09 |
2013-09-10 |
Нестек С.А. |
Способы уменьшения аллергических реакций, вызванных аллергенами окружающей среды
|
WO2009029831A1
(en)
|
2007-08-31 |
2009-03-05 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
US20110166328A1
(en)
*
|
2008-09-02 |
2011-07-07 |
Huan Nguyen |
Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
HUE057713T2
(hu)
|
2009-04-03 |
2022-05-28 |
Univ Chicago |
A protein A (SPA) variánsaival kapcsolatos készítmények és módszerek
|
BRPI1014774A2
(pt)
|
2009-04-27 |
2019-04-16 |
Immuron Limited |
preparacao de imunoglobulina enriquecida anti-lps para uso no tratamento e/ou na profilaxia de um disturbio patologico
|
US10266585B2
(en)
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
WO2011140550A2
(en)
*
|
2010-05-07 |
2011-11-10 |
Camas Incorporated |
Immunogen adherence and method of making and using same
|
WO2012003474A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
DK2605791T3
(da)
|
2010-08-17 |
2017-06-19 |
Immuron Ltd |
Anti-lps-beriget immunoglobulinpræparat til anvendelse i behandling og/eller profylakse af en patologisk lidelse
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
KR102037885B1
(ko)
*
|
2010-11-23 |
2019-10-30 |
팬더릭스 인코포레이티드 |
광범위한, 미확인 또는 혼합된 임상적 적용에서 치료용 조성물들 및 방법들
|
DE102011006781A1
(de)
*
|
2011-04-05 |
2012-10-11 |
Mat-Malta Advanced Technologies Limited |
Antikörperprodukt, umfassend n spezifische Antikörper
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
US9556281B2
(en)
|
2011-08-15 |
2017-01-31 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein A
|
WO2013162746A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
EP2841101B1
(en)
|
2012-04-26 |
2019-08-07 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
ES2940827T3
(es)
|
2013-04-19 |
2023-05-11 |
Immuron Ltd |
Procedimientos y composiciones para el tratamiento y/o la profilaxis de la enfermedad asociada a Clostridium difficile
|
US10716850B2
(en)
|
2014-12-31 |
2020-07-21 |
Wellin, Inc. |
Anti-inflammatory factor retentate, method of isolation, and use
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
US10166280B2
(en)
|
2016-06-08 |
2019-01-01 |
Epitopix, Llc |
Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
US11339387B2
(en)
|
2018-05-22 |
2022-05-24 |
The Government Of The United States Of America As Represented By The Secretary Of Homeland Security |
Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
|
US11701423B2
(en)
|
2021-03-12 |
2023-07-18 |
Lay Sciences, Inc. |
Hyperimmunized egg product for treatment or prevention of coronavirus infection
|
WO2022243769A1
(en)
|
2021-05-17 |
2022-11-24 |
Societe Des Produits Nestle Sa |
Cat food supplements comprising an anti-fel-d1 molecule and an animal digest
|
WO2023212604A1
(en)
|
2022-04-27 |
2023-11-02 |
Lay Sciences, Inc. |
Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
|
WO2023220243A1
(en)
|
2022-05-13 |
2023-11-16 |
Prodigy Biotech, Inc. |
Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof
|